MedPath

A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users - ND

Conditions
Heroin Users
MedDRA version: 6.1Level: PTClassification code 10013663
Registration Number
EUCTR2006-005235-14-IT
Lead Sponsor
ESSEX ITALIA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
310
Inclusion Criteria

Subjects must be male or non-pregnant, non-lactating females age 15 years or older and of any race. Subjects must meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for opioid dependence. All subjects must have a methadoneand buprenorphine-negative UDS result before randomization.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Subjects will not have had methadone or buprenorphine maintenance or detoxification within 30 days of enrollment. Women of childbearing potential must have a negative urine beta-human chorionic gonadotropin pregnancy test before enrollment, and all subjects must agree to use a medically acceptable form of contraception for the duration of the study.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath